These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 23647808)

  • 1. Liver surgery in the multidisciplinary management of gastrointestinal stromal tumour.
    Cananzi FC; Belgaumkar AP; Lorenzi B; Mudan S
    ANZ J Surg; 2014 Dec; 84(12):E1-8. PubMed ID: 23647808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver surgery in the multidisciplinary management of gastrointestinal stromal tumour.
    Cananzi FC; Belgaumkar A; Lorenzi B; Mudan S
    ANZ J Surg; 2014 Dec; 84(12):937-42. PubMed ID: 25444423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib -- analysis of prognostic factors (EORTC-STBSG collaborative study).
    Bauer S; Rutkowski P; Hohenberger P; Miceli R; Fumagalli E; Siedlecki JA; Nguyen BP; Kerst M; Fiore M; Nyckowski P; Hoiczyk M; Cats A; Casali PG; Treckmann J; van Coevorden F; Gronchi A
    Eur J Surg Oncol; 2014 Apr; 40(4):412-9. PubMed ID: 24491288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal stromal tumor (GIST) with liver metastases: An 18-year experience from the GIST cooperation group in North China.
    Shi YN; Li Y; Wang LP; Wang ZH; Liang XB; Liang H; Zhang L; Li B; Fan LQ; Zhao Q; Ma ZX; Zhao XF; Zhang ZD; Liu Y; Tan BB; Wang D; Wang LL; Hao YJ; Jia N
    Medicine (Baltimore); 2017 Nov; 96(46):e8240. PubMed ID: 29145240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib.
    Andtbacka RH; Ng CS; Scaife CL; Cormier JN; Hunt KK; Pisters PW; Pollock RE; Benjamin RS; Burgess MA; Chen LL; Trent J; Patel SR; Raymond K; Feig BW
    Ann Surg Oncol; 2007 Jan; 14(1):14-24. PubMed ID: 17072676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of operative therapy in treatment of metastatic gastrointestinal stromal tumors.
    Zaydfudim V; Okuno SH; Que FG; Nagorney DM; Donohue JH
    J Surg Res; 2012 Oct; 177(2):248-54. PubMed ID: 22831567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical treatment of locally advanced, non-metastatic, gastrointestinal stromal tumours after treatment with imatinib.
    Tielen R; Verhoef C; van Coevorden F; Gelderblom H; Sleijfer S; Hartgrink HH; Bonenkamp JJ; van der Graaf WT; de Wilt JH
    Eur J Surg Oncol; 2013 Feb; 39(2):150-5. PubMed ID: 23084087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resection of focally progressive gastrointestinal stromal tumours resistant to imatinib therapy.
    Tse GH; Wong EH; O'Dwyer PJ
    Surgeon; 2012 Dec; 10(6):309-13. PubMed ID: 22123434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of long-term survival after hepatectomy for isolated liver metastasis of gastrointestinal stromal tumour.
    Cheung TT; Chok KS; Chan AC; Yau TC; Chan SC; Poon RT; Fan ST; Lo CM
    ANZ J Surg; 2014 Nov; 84(11):827-31. PubMed ID: 23782558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of surgery on advanced gastrointestinal stromal tumors (GIST) in the imatinib era.
    Bonvalot S; Eldweny H; Péchoux CL; Vanel D; Terrier P; Cavalcanti A; Robert C; Lassau N; Cesne AL
    Ann Surg Oncol; 2006 Dec; 13(12):1596-603. PubMed ID: 16957966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgery including liver resection for metastatic gastrointestinal stromal tumors or gastrointestinal leiomyosarcomas.
    Nunobe S; Sano T; Shimada K; Sakamoto Y; Kosuge T
    Jpn J Clin Oncol; 2005 Jun; 35(6):338-41. PubMed ID: 15928191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical characteristics and the role of surgery and imatinib treatment in patients with liver metastases from c-Kit positive gastrointestinal stromal tumors (GIST).
    Rutkowski P; Nyckowski P; Grzesiakowska U; Nowecki ZI; Nasierowska-Guttmejer A; Pienkowski A; Dudek K; Krawczyk M; Ruka W
    Neoplasma; 2003; 50(6):438-42. PubMed ID: 14689066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resection of liver metastases in patients with gastrointestinal stromal tumors in the imatinib era: A nationwide retrospective study.
    Seesing MF; Tielen R; van Hillegersberg R; van Coevorden F; de Jong KP; Nagtegaal ID; Verhoef C; de Wilt JH;
    Eur J Surg Oncol; 2016 Sep; 42(9):1407-13. PubMed ID: 27038995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of surgical cytoreduction prior to imatinib therapy on the prognosis of patients with advanced GIST.
    An HJ; Ryu MH; Ryoo BY; Sohn BS; Kim KH; Oh ST; Yu CS; Yook JH; Kim BS; Kang YK
    Ann Surg Oncol; 2013 Dec; 20(13):4212-8. PubMed ID: 24052319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a role of surgery in patients with recurrent or metastatic gastrointestinal stromal tumours responding to imatinib: a prospective randomised trial in China.
    Du CY; Zhou Y; Song C; Wang YP; Jie ZG; He YL; Liang XB; Cao H; Yan ZS; Shi YQ
    Eur J Cancer; 2014 Jul; 50(10):1772-1778. PubMed ID: 24768330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of metastasectomy for recurrent/metastatic gastrointestinal stromal tumors based on an analysis of the Kinki GIST registry.
    Sato S; Tsujinaka T; Masuzawa T; Yamamoto K; Takahashi T; Yamashita Y; Fujita J; Takagi M; Hirota S; Nishida T
    Surg Today; 2017 Jan; 47(1):58-64. PubMed ID: 27194124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary surgery as a frontline treatment for synchronous metastatic gastrointestinal stromal tumors: an analysis of the Kinki GIST registry.
    Sato S; Tsujinaka T; Yamamoto K; Takahashi T; Kishi K; Imamura H; Fujita J; Takagi M; Hirota S; Nishida T
    Surg Today; 2016 Sep; 46(9):1068-75. PubMed ID: 26611538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of surgical resection following imatinib treatment in patients with recurrent or metastatic gastrointestinal stromal tumors: results of propensity score analyses.
    Park SJ; Ryu MH; Ryoo BY; Park YS; Sohn BS; Kim HJ; Kim CW; Kim KH; Yu CS; Yook JH; Kim BS; Kang YK
    Ann Surg Oncol; 2014 Dec; 21(13):4211-7. PubMed ID: 24980089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for primary gastrointestinal stromal tumours: are they the same in the multidisciplinary treatment era?
    Cananzi FC; Lorenzi B; Belgaumkar A; Benson C; Judson I; Mudan S
    Langenbecks Arch Surg; 2014 Mar; 399(3):323-32. PubMed ID: 24413830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of 3-year vs 1-year adjuvant therapy with imatinib in patients with high risk of gastrointestinal stromal tumour recurrence in the Netherlands; a modelling study alongside the SSGXVIII/AIO trial.
    Majer IM; Gelderblom H; van den Hout WB; Gray E; Verheggen BG
    J Med Econ; 2013 Sep; 16(9):1106-19. PubMed ID: 23808902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.